Live tape
Top 8, mentions 7d7,350SPCX1,444 mentions▲ +0.09GOOGL1,345 mentions▲ +0.05NVDA1,196 mentions▲ +0.09MSFT840 mentions▲ +0.04QQQ693 mentions▲ +0.08META639 mentions▲ +0.04SPY601 mentions▲ +0.06AMZN592 mentions▲ +0.07

Equity · Healthcare

RLMD

NASDAQ

Relmada Therapeutics, Inc.

$5.23 +4.50% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for RLMD to draw a line in its place.

Market cap $557.3M
52-week range $0.563 – $7.88
Avg volume 526.2K

as of Jul 17, 2026

RLMD insider trades

SEC Form 4

RLMD has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 15 December 2025.

Date Insider Type Shares Value
15 Dec 2025 Shenouda Maged Chief Financial Officer Buy 11,665 $48K
15 Dec 2025 TRAVERSA SERGIO Chief Executive Officer Buy 27,500 $113K
05 Nov 2025 Kelly Paul Edward Chief Operating Officer Buy 90,000 $198K
05 Nov 2025 Shenouda Maged Chief Financial Officer Buy 500,000 $1.10M
05 Nov 2025 TRAVERSA SERGIO Chief Executive Officer Buy 272,500 $600K
05 Nov 2025 Ence Chuck CAO and COO Buy 136,000 $299K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Dec 2025 CASAMENTO CHARLES J Award 164,000
12 Dec 2025 Kelly Paul Edward COO Award 828,000
12 Dec 2025 GLASSPOOL JOHN Award 164,000
12 Dec 2025 Fedeli Fabiana Award 164,000
12 Dec 2025 Ence Chuck CA and CO Award 828,000
12 Dec 2025 Shenouda Maged Chief Financial Officer Award 828,000
12 Dec 2025 TRAVERSA SERGIO Chief Executive Officer Award 1,198,000

RLMD reported financials

SEC EDGAR XBRL SEC EDGAR

RLMD reported net income of −$57.4M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$57.4M 31 Dec 2025 fiscal year
Diluted EPS −$1.45 31 Dec 2025 fiscal year
Total assets $219.1M 30 Jun 2026 at period end
Total equity $206.6M 30 Jun 2026 at period end

RLMD earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.11 —
31 Mar 2026 Q1 2026 −$0.22 —
31 Dec 2025 FY 2025 −$1.45 —
30 Sep 2025 Q3 2025 −$0.30 —
30 Jun 2025 Q2 2025 −$0.30 —
31 Mar 2025 Q1 2025 −$0.58 —
31 Dec 2024 FY 2024 −$2.65 —
30 Sep 2024 Q3 2024 −$0.72 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

RLMD institutional holders

SEC Form 13F SEC EDGAR

7 of the 45 institutional funds we track reported a RLMD position for the quarter ended 30 Jun 2026 — a combined $52.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Trimmed −39.6% shares 2,361,827 $16.3M
Marshall Wace Trimmed −49.9% shares 2,246,839 $15.5M
Balyasny Asset Management Added +502.4% shares 1,520,688 $10.5M
Citadel Advisors New position 1,061,665 $7.3M
Two Sigma Investments Trimmed −47.3% shares 214,915 $1.5M
D. E. Shaw & Co. New position 109,474 $758K
Renaissance Technologies Trimmed −65.4% shares 57,800 $400K

RLMD fails-to-deliver

SEC CNS data SEC

On 27 Aug 2026, 150 shares of RLMD failed to deliver (about $683).

Settlement date Shares failed Notional % of shares out
27 Aug 2026 150 $683 <0.001%

Congressional trades in RLMD

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in RLMD is a sale by Sara Jacobs (house, CA), dated 12 Dec 2022.

Date Member Type Amount
12 Dec 2022 filed 20 Jan 2023 Sara Jacobs house · Democrat–CA Sale $1K–$15K
08 Nov 2022 filed 12 Dec 2022 Sara Jacobs house · Democrat–CA Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings